Additionally, RANKL/RANK signaling activation can regulate the NF-κB signaling pathway to inhibit B cell apoptosis, promoting B cell survival and proliferation capacity, providing a protective environment for lung cancer cells to escape immune surveillance, thereby inhibiting lung cancer cell apoptosis and promoting bone metastasis (69). Here, NFKB1 is linked to lung carcinoma.